OFIX Earnings & Financial Statements
Orthofix Medical Inc.
$9.25
-$0.01(-0.11%)
35
Overall
50
Value
10
Tech
47
Quality
Market Cap
$376.78M
Volume
292.20K
52W Range
$8.50 - $16.99
Target Price
$13.00
OFIX earnings and financial statements: Orthofix Medical Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
OFIX Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $822.31M | $799.49M | $746.64M | $460.71M | $464.48M |
| Cost of revenue | $256.30M | $253.61M | $260.37M | $123.54M | $114.91M |
| Operating income | -$81.43M | -$84.62M | -$139.11M | -$13.27M | -$8.31M |
| EBITDA | -$73.32M | -$94.24M | -$86.98M | $15.66M | $21.44M |
| Net income | -$92.19M | -$126.00M | -$151.40M | -$19.75M | -$38.38M |
| EPS (diluted) | $-2.33 | $-3.30 | $-4.12 | $-0.98 | $-1.95 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $850.65M | $893.29M | $925.32M | $458.63M | $476.62M |
| Total liabilities | $400.61M | $390.17M | $326.58M | $121.77M | $139.69M |
| Shareholders’ equity | $450.04M | $503.12M | $598.73M | $336.86M | $336.93M |
| Cash and equivalents | $82.03M | $83.24M | $33.11M | $50.70M | $87.85M |
| Long-term debt | $174.45M | $174.85M | $111.64M | $19.24M | $19.89M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $33.35M | $25.79M | -$45.75M | -$11.54M | $18.48M |
| Capital expenditure | -$34.63M | -$34.88M | -$62.05M | -$23.16M | -$19.59M |
| Free cash flow | -$1.28M | -$9.09M | -$107.80M | -$34.70M | -$1.12M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | OFIX | $9.25 | -0.1% | 292.20K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |